Cargando…

An Integrated Pharmacokinetic Study of an Acanthopanax senticosus Extract Preparation by Combination of Virtual Screening, Systems Pharmacology, and Multi-Component Pharmacokinetics in Rats

In this paper, the integrated pharmacokinetics (PK) of an Acanthopanax senticosus extract preparation (ASEP, named as Ciwujia injection in clinic in China) was explored by combining with multi-component PK in rats, virtual screening, systems pharmacology and molecular docking. Firstly, the ingredien...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Peiying, Xie, Yunjiao, Xie, Rongfang, Lin, Zuan, Yao, Hong, Wu, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457137/
https://www.ncbi.nlm.nih.gov/pubmed/32922299
http://dx.doi.org/10.3389/fphar.2020.01295
_version_ 1783575943439187968
author Shi, Peiying
Xie, Yunjiao
Xie, Rongfang
Lin, Zuan
Yao, Hong
Wu, Shuang
author_facet Shi, Peiying
Xie, Yunjiao
Xie, Rongfang
Lin, Zuan
Yao, Hong
Wu, Shuang
author_sort Shi, Peiying
collection PubMed
description In this paper, the integrated pharmacokinetics (PK) of an Acanthopanax senticosus extract preparation (ASEP, named as Ciwujia injection in clinic in China) was explored by combining with multi-component PK in rats, virtual screening, systems pharmacology and molecular docking. Firstly, the ingredients in ASEP with high contents and detectable property in rat plasma were selected. Next, the PK study of the resulted ingredients was performed in rats (1.76 ml/kg and 3.52 ml/kg of 5 times concentrated ASEP, single i.v.). Meanwhile, the drug targets for the ingredients screened out were predicted by using a target fishing online server, PharmMapper (http://www.lilab-ecust.cn/pharmmapper/) with a fit filtration threshold of z’-score >0. Next, the network pharmacology, molecular docking, diseases ontology (DO) analysis, and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis were performed respectively for the predicted targets. Finally, the supporting evidences were obtained to characterize the PK markers and carry out the integrated PK study with “plasma-drug concentration sum” or “plasma-drug AUC weighted” methods. As a result, 6 ingredients, involving 5-caffeoylquinic acid (5-CQA), 3-CQA, 4-CQA, protocatechuic acid, eleutheroside B, and gentiopicroside were selected, and their PK profiles were elucidated. The 6 ingredients were highly related to arteriosclerotic cardiovascular disease and atherosclerosis and could mainly interact with similar targets, e.g., GSK3B, PDPK1, PLAU, etc., or pathways, e.g., Insulin, VEGF, FoxO, etc, providing the basis for integrating plasma drug concentration. Ultimately, the 6 ingredients were considered as PK markers and the whole in vivo process of ASEP were characterized. Our study would enhance understanding of the therapeutic effects and mechanisms of ASEP against cardiovascular diseases, and provided useful insights for future integrated PK study on anti-cardiovascular diseases TCM injections.
format Online
Article
Text
id pubmed-7457137
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74571372020-09-11 An Integrated Pharmacokinetic Study of an Acanthopanax senticosus Extract Preparation by Combination of Virtual Screening, Systems Pharmacology, and Multi-Component Pharmacokinetics in Rats Shi, Peiying Xie, Yunjiao Xie, Rongfang Lin, Zuan Yao, Hong Wu, Shuang Front Pharmacol Pharmacology In this paper, the integrated pharmacokinetics (PK) of an Acanthopanax senticosus extract preparation (ASEP, named as Ciwujia injection in clinic in China) was explored by combining with multi-component PK in rats, virtual screening, systems pharmacology and molecular docking. Firstly, the ingredients in ASEP with high contents and detectable property in rat plasma were selected. Next, the PK study of the resulted ingredients was performed in rats (1.76 ml/kg and 3.52 ml/kg of 5 times concentrated ASEP, single i.v.). Meanwhile, the drug targets for the ingredients screened out were predicted by using a target fishing online server, PharmMapper (http://www.lilab-ecust.cn/pharmmapper/) with a fit filtration threshold of z’-score >0. Next, the network pharmacology, molecular docking, diseases ontology (DO) analysis, and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis were performed respectively for the predicted targets. Finally, the supporting evidences were obtained to characterize the PK markers and carry out the integrated PK study with “plasma-drug concentration sum” or “plasma-drug AUC weighted” methods. As a result, 6 ingredients, involving 5-caffeoylquinic acid (5-CQA), 3-CQA, 4-CQA, protocatechuic acid, eleutheroside B, and gentiopicroside were selected, and their PK profiles were elucidated. The 6 ingredients were highly related to arteriosclerotic cardiovascular disease and atherosclerosis and could mainly interact with similar targets, e.g., GSK3B, PDPK1, PLAU, etc., or pathways, e.g., Insulin, VEGF, FoxO, etc, providing the basis for integrating plasma drug concentration. Ultimately, the 6 ingredients were considered as PK markers and the whole in vivo process of ASEP were characterized. Our study would enhance understanding of the therapeutic effects and mechanisms of ASEP against cardiovascular diseases, and provided useful insights for future integrated PK study on anti-cardiovascular diseases TCM injections. Frontiers Media S.A. 2020-08-14 /pmc/articles/PMC7457137/ /pubmed/32922299 http://dx.doi.org/10.3389/fphar.2020.01295 Text en Copyright © 2020 Shi, Xie, Xie, Lin, Yao and Wu http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Shi, Peiying
Xie, Yunjiao
Xie, Rongfang
Lin, Zuan
Yao, Hong
Wu, Shuang
An Integrated Pharmacokinetic Study of an Acanthopanax senticosus Extract Preparation by Combination of Virtual Screening, Systems Pharmacology, and Multi-Component Pharmacokinetics in Rats
title An Integrated Pharmacokinetic Study of an Acanthopanax senticosus Extract Preparation by Combination of Virtual Screening, Systems Pharmacology, and Multi-Component Pharmacokinetics in Rats
title_full An Integrated Pharmacokinetic Study of an Acanthopanax senticosus Extract Preparation by Combination of Virtual Screening, Systems Pharmacology, and Multi-Component Pharmacokinetics in Rats
title_fullStr An Integrated Pharmacokinetic Study of an Acanthopanax senticosus Extract Preparation by Combination of Virtual Screening, Systems Pharmacology, and Multi-Component Pharmacokinetics in Rats
title_full_unstemmed An Integrated Pharmacokinetic Study of an Acanthopanax senticosus Extract Preparation by Combination of Virtual Screening, Systems Pharmacology, and Multi-Component Pharmacokinetics in Rats
title_short An Integrated Pharmacokinetic Study of an Acanthopanax senticosus Extract Preparation by Combination of Virtual Screening, Systems Pharmacology, and Multi-Component Pharmacokinetics in Rats
title_sort integrated pharmacokinetic study of an acanthopanax senticosus extract preparation by combination of virtual screening, systems pharmacology, and multi-component pharmacokinetics in rats
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457137/
https://www.ncbi.nlm.nih.gov/pubmed/32922299
http://dx.doi.org/10.3389/fphar.2020.01295
work_keys_str_mv AT shipeiying anintegratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats
AT xieyunjiao anintegratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats
AT xierongfang anintegratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats
AT linzuan anintegratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats
AT yaohong anintegratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats
AT wushuang anintegratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats
AT shipeiying integratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats
AT xieyunjiao integratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats
AT xierongfang integratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats
AT linzuan integratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats
AT yaohong integratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats
AT wushuang integratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats